The Pharmasyntez Group of Companies is set to significantly boost their drug exports in the coming two years. With a solid foundation of signed contracts already in motion, the company aims to increase their export volume by an impressive 5-10 times. Nikita Punia, the executive director of the company, made an announcement during the VIII Annual Biotechmed Forum held in Sochi on October 9-10.
“We have already registered over 100 drugs internationally, and we are currently focusing on developing a range of registered drugs in EAEU countries. We firmly believe that in the next year or two, we will significantly increase our export sales by 5-10 times. In order to achieve this, we are also expanding our line of drugs, which now includes hormonal drugs, urology medications, and even parenteral nutrition. Our commitment to growth means that we will continue to expand our product lines in the upcoming years,” the spokesperson confidently informed the reporters.
